Latest filing published 25 Sept 2026 for BioSyent Inc., €10k. Read the official filing
Seyed Ahmad Ashrafi discloses dealings in BioSyent Inc. to SEDI. We count 45 filings; the first trade dates from 12 February 2016 and the latest from 22 September 2026.
The open-market record consists of 14 sales worth €146k, with no purchase. Other entries cover 8 share grants and 21 option exercises. 2026 to date brings no purchases and 14 sales.
Most recently, on 25 September 2026, the filings show an open-market sale worth €10k in BioSyent Inc. Filings reach the SEDI feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 45 declarations